直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Olivia J. Santiago
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4046
olivia.santiago@finnegan.com olivia.santiago@finnegan.com

Olivia J. Santiago

Associate

  • +1 202 408 4046 +1 202 408 4046
  • olivia.santiago@finnegan.com olivia.santiago@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Olivia Santiago practices in all areas of intellectual property (IP) law, including prosecution, post-grant proceedings, licensing, and strategic IP counseling. She works with clients across a variety of industries, including the pharmaceutical, biotechnology, chemical, and computer software sectors.

Olivia drafts and prosecutes patent applications relating to pharmaceutical products, biotechnology innovations, chemical technologies, and computer software before the U.S. Patent and Trademark Office (USPTO). Her litigation experience includes developing invalidity and infringement theories, working with experts, and drafting petitions before the Patent Trial and Appeal Board (PTAB) of the USPTO. 

 

Olivia advises clients on IP licensing and other commercial matters involving IP assets. Her experience extends to contract matters, due diligence, counseling on patent validity and freedom-to-operate (FTO) issues, and enforcement efforts. 

 

Olivia is committed to pro bono practice, which includes representing disabled veterans in appellate proceedings as a part of the firm’s Veteran’s Assistance Program.

 

Et Cetera

  • Member, Fordham Intellectual Property, Media and Entertainment Law Journal, 2022-2023.
  • Participant, International Commercial Mediation Competition, International Chamber of Commerce (ICC), 2023.

Experience

Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof

Representing respondent Wacker Biotech GmbH in a rare section 337 ITC investigation involving drug products containing C-type natriuretic peptide variants.

337-TA-1447, ITC, Judge Cheney

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

Represented Rocket Pharmaceuticals, Inc. in district court litigation involving claims of trade secret misappropriation and breach of contract against individual and corporate defendants and relating to complex treatments for genetic disorders. Successfully opposed motion to dismiss key claims and obtained settlement with all defendants following completion of fact discovery.

1:23-cv-09000, S.D.N.Y., Judges Castel, Aaron

Insights

Articles

Trending at the PTAB: Petitioners' Settled Expectations

Trending at the PTAB: Petitioners' Settled Expectations Trending at the PTAB: Petitioners' Settled Expectations

October 1, 2025

Law360

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – June 2025 Spotlight on Upcoming Oral Arguments – June 2025

May 29, 2025

Articles

An Implied Copyright License Requires a “Meeting of the Minds” on how the Copyright is to be Used – Permission to a Television Host to Wear a Clothing Design Did Not Imply a License to a Toy Company to use the Design on Toy Figurines

An Implied Copyright License Requires a “Meeting of the Minds” on how the Copyright is to be Used – Permission to a Television Host to Wear a Clothing Design Did Not Imply a License to a Toy Company to use the Design on Toy Figurines An Implied Copyright License Requires a “Meeting of the Minds” on how the Copyright is to be Used – Permission to a Television Host to Wear a Clothing Design Did Not Imply a License to a Toy Company to use the Design on Toy Figurines

July 20, 2023

LES Insights

Articles

D. Mass. Patent Litigation Update: May 2023

D. Mass. Patent Litigation Update: May 2023 D. Mass. Patent Litigation Update: May 2023

June 29, 2023

News

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll 61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Award/Ranking

56 Finnegan Attorneys Recognized on the 2024 Capital Pro Bono Honor Roll 56 Finnegan Attorneys Recognized on the 2024 Capital Pro Bono Honor Roll

April 24, 2025

DC Bar
Admissions and Education

Admissions

  • District of Columbia
  • New York

Education

Fordham University School of Law
J.D., 2024
Syracuse University
B.A., Spanish, magna cum laude, 2021
Syracuse University
B.S., Biotechnology, magna cum laude, 2021

Olivia's Practices

Diligence, Licensing, and Opinions
Freedom to Operate Opinions
Licensing, Pooling, and Other Transactions
Opinions and Counseling
Global IP Enforcement, Litigation, and Trials
Patent Litigation and Trials
Patent Office Invalidation Proceedings
PTAB Invalidation Proceedings: IPR and PGR
Prosecution and Portfolio Management
Copyright
Patent Drafting and Prosecution
Trademark Counseling and Prosecution

Olivia's Industries

AI, Electronics, and Information Technology
Electrical and Computer Technology
Electronic Devices and Components
Chemicals, Industrials, and Materials
Chemical
Communications
Financial Services and Business Systems
Consumer Goods and Services
Consumer Products
Life Sciences
Biologics
Biotechnology
Medical Device and Diagnostics
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP